Should Aspirin Be Used for Primary Prevention in the Post-Statin Era?

N Engl J Med. 2018 Oct 18;379(16):1572-1574. doi: 10.1056/NEJMe1812000.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aspirin*
  • Cardiovascular Diseases
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Platelet Aggregation Inhibitors
  • Primary Prevention

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Aspirin